Onkologi i Sverige Nr 4

Pierre Fabre invites to symposium / webinar September 30, 16.00-18.40

LUNGCANCER SYMPOSIUM ON TARGETED THERAPY Prof. Niels Reinmuth, Dr. Ronny Öhman, Dr. Björn Båtshake

Stockholm, August 2025 Intended for Specialists with an interest in NSCLC.

We are pleased to invite you to the meeting ” Lungcancer Symposium on Targeted Therapy ” in Lund on September 30, 2025 . During this meeting, experts will discuss the latest insights in the treatment of targeted therapy in NSCLC with focus on BRAF mutated NSCLC. Special invited speaker: Professor Niels Reinmuth, Asklepios Lung Clinic Gauting, München, Germany, Senior consultants Ronny Öhman, and Björn Båtshake at Skåne University Hospital in Lund.

Venue: Föreläsningssal 4, Blocket, Skånes universitetssjukhus Lund . The meeting will be streamed live as well. Register below.

Program

16:00 – 16:30 Coffee 16:30 – 16:40 Introduction, Senior Consultant Ronny Öhman, Skåne University hospital Lund 16:40 – 17:25 Challenges and future directions for treatment of NSCLC with

17:45 – 18:00 Break 18:00 – 18:30 Patient cases and discussion, Senior Consultant Ronny Öhman, and Prof Niels Reinmuth 18:30 – 18:40 Closing remarcs, Senior Consultant Ronny Öhman

oncogenic mutations, Prof. Niels Reinmuth, Asklepios Lung Clinic Gauting, München, Germany

17:25 – 17:45 Practical experience from Malignant Melanoma, Senior

Consultant Björn Båtshake, Skåne University hospital Lund

Prof Niels Reinmuth background Dr. Niels Reinmuth is a certified specialist in ”General Medicine”, Hematology/Oncology, and Pneumology, with a postdoctoral qualification from the University of Heidelberg. He was Senior Physician at the Lung Clinic Grosshansdorf (2012–2016) and has led the Thoracic Oncology Department at Asklepios Lung Clinic Munich-Gauting since 2016. His main interests include targeted therapies for non-small-cell lung cancer, new treatments for small-cell lung cancer and malignant pleural mesothelioma, and translational research on predictive markers. He is a member of several professional societies, including IASLC, ESMO, and ASCO.

Registration can be made to Michael Rustner via email, michael.rustner.ext@pierre-fabre.com, or through the QR code.

Pierre Fabre Pharma Norden AB Karlavägen 108, Plan 9 115 26 Stockholm | Sweden

© 2025 Pierre Fabre, all rights reserved. BRAFTOVI ® is a trademark of Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc.

SE-BRH-08-25-2500002 aug 2025